HeadInvest LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
2,530
-476
| -16% | -$212K | 0.24% | 79 |
|
|
2025
Q1 | $1.46M | Buy |
3,006
+311
| +12% | +$151K | 0.28% | 76 |
|
|
2024
Q4 | $1.09M | Sell |
2,695
-173
| -6% | -$69.7K | 0.2% | 86 |
|
|
2024
Q3 | $1.33M | Buy |
2,868
+410
| +17% | +$191K | 0.25% | 79 |
|
|
2024
Q2 | $1.15M | Buy |
2,458
+731
| +42% | +$343K | 0.23% | 84 |
|
|
2024
Q1 | $722K | Buy |
1,727
+679
| +65% | +$284K | 0.14% | 110 |
|
|
2023
Q4 | $426K | Sell |
1,048
-25
| -2% | -$10.2K | 0.09% | 156 |
|
|
2023
Q3 | $373K | Hold |
1,073
| – | – | 0.08% | 162 |
|
|
2023
Q2 | $375K | Sell |
1,073
-23
| -2% | -$8.05K | 0.08% | 164 |
|
|
2023
Q1 | $345K | Sell |
1,096
-50
| -4% | -$15.8K | 0.08% | 172 |
|
|
2022
Q4 | $331K | Sell |
1,146
-76
| -6% | -$21.9K | 0.07% | 171 |
|
|
2022
Q3 | $354K | Buy |
1,222
+10
| +0.8% | +$2.9K | 0.08% | 157 |
|
|
2022
Q2 | $342K | Hold |
1,212
| – | – | 0.08% | 163 |
|
|
2022
Q1 | $316K | Sell |
1,212
-17
| -1% | -$4.43K | 0.06% | 183 |
|
|
2021
Q4 | $270K | Buy |
1,229
+60
| +5% | +$13.2K | 0.05% | 206 |
|
|
2021
Q3 | $212K | Sell |
1,169
-27
| -2% | -$4.9K | 0.04% | 218 |
|
|
2021
Q2 | $241K | Buy |
1,196
+41
| +4% | +$8.26K | 0.05% | 204 |
|
|
2021
Q1 | $248K | Buy |
1,155
+122
| +12% | +$26.2K | 0.05% | 200 |
|
|
2020
Q4 | $244K | Buy |
+1,033
| New | +$244K | 0.05% | 189 |
|
|
2015
Q1 | – | Sell |
-3,000
| Closed | -$356K | – | 120 |
|
|
2014
Q4 | $356K | Sell |
3,000
-423
| -12% | -$50.2K | 0.14% | 84 |
|
|
2014
Q3 | $386K | Hold |
3,423
| – | – | 0.15% | 81 |
|
|
2014
Q2 | $324K | Hold |
3,423
| – | – | 0.13% | 89 |
|
|
2014
Q1 | $242K | Hold |
3,423
| – | – | 0.1% | 91 |
|
|
2013
Q4 | $254K | Hold |
3,423
| – | – | 0.11% | 90 |
|
|
2013
Q3 | $260K | Hold |
3,423
| – | – | 0.11% | 90 |
|
|
2013
Q2 | $274K | Buy |
+3,423
| New | +$274K | 0.12% | 92 |
|